Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Sanofi-Aventis Czech Republic generated the highest sales in 2017 followed by Novartis Czech Republic and Roche Czech Republic.
Sanofi-Aventis Czech Republic made total sales of CZK 7,268 mil, up 8.47% compared to the previous year. Historically, the firm’s revenues an all time high of CZK 7,525 mil in 2010 and an all time low of CZK 2,045 mil in 2004.
The average sales growth in the last five years amounted to 0.118%.
Comparing Sanofi-Aventis Czech Republic with its closest peers, Novartis Czech Republic generated a sales of CZK 6,312 mil average sales growth 9.94% in 2017, Roche Czech Republic sold products and services worth CZK 4,962 mil (5-year growth of -100%) and Bayer Czech Republic announced revenues of CZK 4,180 mil translating into average nominal growth of -100% in the last five years.
|Roche Czech Republic||CZK mil||5,011||4,869||4,934||4,364||5,445||...|
|Merck Czech Republic||CZK mil||1,622||1,755||1,726||1,798||1,850|
|Amgen Czech Republic||CZK mil||422||416||468||637||604|
|Pfizer Czech Republic||CZK mil||6,807||3,118||5,407||4,947||3,122|
|Bayer Czech Republic||CZK mil||3,344||3,245||3,438||4,054||4,277|
|GlaxoSmithKline Czech Republic||CZK mil||5,828||5,735||5,653||4,855||4,378|
|Sanofi-Aventis Czech Republic||CZK mil||7,040||7,225||6,531||6,120||6,596|
|Novartis Czech Republic||CZK mil||3,962||3,930||4,056||4,686||5,393|
|Servier Czech Republic||CZK mil||...||...||333||345||440||658|